Biospecimen Collection for Breast Cancer

This trial aims to gather clinical information and collect tissue and blood samples from patients with recurrent or stage IV breast cancer. By creating a registry of this data, researchers hope to better understand how tumors spread and why individuals respond differently to cancer treatments. The trial seeks participants with confirmed invasive breast cancer that has spread or progressed and who have accessible tumors for biopsy. As an unphased trial, this study offers patients the opportunity to contribute to vital research that could enhance future cancer treatments.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with your doctor or the trial team.

Researchers are excited about this trial because it offers a unique approach to understanding recurrent or stage IV breast cancer. Unlike standard treatments that focus on directly targeting tumors with drugs or radiation, this study collects tissue and blood samples for genetic testing. By analyzing patients' genetic information and clinical data over time, researchers hope to identify new patterns and potentially discover more effective, personalized treatment options in the future. This method could lead to breakthroughs in how these cancers are treated, offering hope for more tailored and effective therapies.